ARCHIVES

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

This article is from The Cancer Letter archive.

Vol. 25 No. 33 | September 3, 1999

Download PDF Visit The Full Archive

Related Articles

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

In Brief: Fabien Calvo named chief scientific officer of Cancer Core Europe

December 19, 2014

In Brief: Ovarian Cancer Coalition Opens Office; Winchester Leads Surgical Oncologists

July 11, 1997

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

June 30, 1978

Senators Urge Grassroots Support For Health Research Fund Legislation

May 16, 1997

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

February 6, 2004